PrimeRFP SCOUT · Federal Contract Recompete Brief

HT001424F0075Immunohistochemistry antibodies special STAIN — Roche Diagnostics Corp

Roche Diagnostics Corp holds $245.9M across 1,391 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 5 related awards under parent HT001421A0001. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. PoP ended Mar 28, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Defense Health Agency

Awarding office

Roche Diagnostics Corp

Recipient

Mar 28, 2024

PoP end

$1.6M

Obligated

$1.6M

Potential

622110

NAICS

6515

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Roche Diagnostics Corp — $90

Contract facts

NONE

Contract numberHT001424F0075

Also listed asHT0014-24-F-0075

Also listed asHT001421A0001-HT001424F0075

AgencyDefense Health Agency

Awarding officeDefense Health Agency

Awarding agencyDepartment of Defense (DOD)

Funding agencyDepartment of Defense (DOD)

IncumbentRoche Diagnostics Corp

CAGE51169

UEIJDMDFEZBYH36

NAICS622110

No full NAICS 622110 intel page yet. Browse NAICS intelligence

PSC6515

Parent IDIQ / IDVHT001421A0001

Place of performanceBETHESDA MD

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

PoP startMar 28, 2024

PoP end (current)Mar 28, 2024

Obligated$1.6M

Current value$1.6M

Potential value$1.6M

IMMUNOHISTOCHEMISTRY ANTIBODIES, SPECIAL STAIN REAGENTS, AND ROUTINE H&E REAGENTS is a federal NONE award for Defense Health Agency held by Roche Diagnostics Corp. Estimated value $1.6M ($1.6M obligated). Current period of performance ends Mar 28, 2024. Last award drew 1 bidder. Place of performance: BETHESDA MD.

IMMUNOHISTOCHEMISTRY ANTIBODIES, SPECIAL STAIN REAGENTS, AND ROUTINE H&E REAGENTS

Recompete timing

Public

● Past PoP end (876 days ago)

Current PoP ended Mar 28, 2024 (876 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Roche Diagnostics Corp — $245.9M obligated across 1,391 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($245.9M) · all agencies

Department of Veterans Affairs (VA)$154.1M · 63%Department of Defense (DOD)$77.5M · 32%Department of Health and Human Services (HHS)$10.4M · 4%Department of Justice (DOJ)$3.0M · 1%

Open full company profile →

Related awards

Same parent · incumbent

36C26225N0151

CHEMISTRY IMMUNOASSAY SYSTEM CPT

$5.9M

Aug 31, 2026

36C25025N1021

FSS-BPA ROCHE COBAS 4800 REAGENTS, CONSUMABLES, CONTROLS.

$600K

Aug 31, 2026

FA480321F0055

ROCHE COVID TEST KITS

$159K

Aug 31, 2026

36C25025N1000

COBA REAGENTS/CONSUMABLES

$135K

Aug 31, 2026

36C25726P0473

BENCHMARK ULTRA PLUS

$132K

Aug 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract HT001424F0075?

HT001424F0075 (Immunohistochemistry antibodies special STAIN) is a Defense Health Agency award with a potential value of $1.6M, currently held by Roche Diagnostics Corp. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is HT0014-24-F-0075?

HT0014-24-F-0075 is the dashed form of PIID HT001424F0075 (Immunohistochemistry antibodies special STAIN), held by Roche Diagnostics Corp. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded HT001424F0075?

Defense Health Agency awarded HT001424F0075 to Roche Diagnostics Corp (potential $1.6M).

Who is the incumbent on HT001424F0075?

Roche Diagnostics Corp is the incumbent with $245.9M across 1391 related awards in SCOUT’s public footprint. The current period of performance ends Mar 28, 2024.

When does Roche Diagnostics Corp’s HT001424F0075 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 28, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Mar 25, 2024